<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;fc=20230708114047&amp;utm_medium=rss&amp;ff=20240731121134&amp;utm_campaign=pubmed-2
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;fc=20230708114047&amp;utm_medium=rss&amp;ff=20240731121134&amp;utm_campaign=pubmed-2" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Wed, 31 Jul 2024 16:11:35 +0000</lastbuilddate>
<pubDate>Wed, 31 Jul 2024 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>AMPK Attenuation of β-Adrenergic Receptor-Induced Cardiac Injury via Phosphorylation of β-Arrestin-1-ser330</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39082138/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240731121134&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: AMPK phosphorylation of β-arrestin-1 Ser330 potentiated PDE4 expression and activity, thereby inhibiting β-AR/cAMP/PKA activation. Subsequently, β-arrestin-1 Ser330 phosphorylation blocks β-AR-induced cardiac inflammasome activation and remodeling.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Jul 31. doi: 10.1161/CIRCRESAHA.124.324762. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: β-adrenergic receptor (β-AR) overactivation is a major pathological cue associated with cardiac injury and diseases. AMPK (AMP-activated protein kinase), a conserved energy sensor, regulates energy metabolism and is cardioprotective. However, whether AMPK exerts cardioprotective effects via regulating the signaling pathway downstream of β-AR remains unclear.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Using immunoprecipitation, mass spectrometry, site-specific mutation, in vitro kinase assay, and in vivo animal studies, we determined whether AMPK phosphorylates β-arrestin-1 at serine (Ser) 330. Wild-type mice and mice with site-specific mutagenesis (S330A knock-in [KI]/S330D KI) were subcutaneously injected with the β-AR agonist isoproterenol (5 mg/kg) to evaluate the causality between β-adrenergic insult and β-arrestin-1 Ser330 phosphorylation. Cardiac transcriptomics was used to identify changes in gene expression from β-arrestin-1-S330A/S330D mutation and β-adrenergic insult.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Metformin could decrease cAMP/PKA (protein kinase A) signaling induced by isoproterenol. AMPK bound to β-arrestin-1 and phosphorylated Ser330 with the highest phosphorylated mass spectrometry score. AMPK activation promoted β-arrestin-1 Ser330 phosphorylation in vitro and in vivo. Neonatal mouse cardiomyocytes overexpressing β-arrestin-1-S330D (active form) inhibited the β-AR/cAMP/PKA axis by increasing PDE (phosphodiesterase) 4 expression and activity. Cardiac transcriptomics revealed that the differentially expressed genes between isoproterenol-treated S330A KI and S330D KI mice were mainly involved in immune processes and inflammatory response. β-arrestin-1 Ser330 phosphorylation inhibited isoproterenol-induced reactive oxygen species production and NLRP3 (NOD-like receptor protein 3) inflammasome activation in neonatal mouse cardiomyocytes. In S330D KI mice, the β-AR-activated cAMP/PKA pathways were attenuated, leading to repressed inflammasome activation, reduced expression of proinflammatory cytokines, and mitigated macrophage infiltration. Compared with S330A KI mice, S330D KI mice showed diminished cardiac fibrosis and improved cardiac function upon isoproterenol exposure. However, the cardiac protection exerted by AMPK was abolished in S330A KI mice.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: AMPK phosphorylation of β-arrestin-1 Ser330 potentiated PDE4 expression and activity, thereby inhibiting β-AR/cAMP/PKA activation. Subsequently, β-arrestin-1 Ser330 phosphorylation blocks β-AR-induced cardiac inflammasome activation and remodeling.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39082138/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240731121134&v=2.18.0.post9+e462414">39082138</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.324762>10.1161/CIRCRESAHA.124.324762</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39082138</guid>
<pubDate>Wed, 31 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Mingming Zhao</dc:creator>
<dc:creator>Ning Cao</dc:creator>
<dc:creator>Huijun Gu</dc:creator>
<dc:creator>Jiachao Xu</dc:creator>
<dc:creator>Wenli Xu</dc:creator>
<dc:creator>Di Zhang</dc:creator>
<dc:creator>Tong-You Wade Wei</dc:creator>
<dc:creator>Kang Wang</dc:creator>
<dc:creator>Ruiping Guo</dc:creator>
<dc:creator>Hongtu Cui</dc:creator>
<dc:creator>Xiaofeng Wang</dc:creator>
<dc:creator>Xin Guo</dc:creator>
<dc:creator>Zhiyuan Li</dc:creator>
<dc:creator>Kangmin He</dc:creator>
<dc:creator>Zijian Li</dc:creator>
<dc:creator>Youyi Zhang</dc:creator>
<dc:creator>John Y-J Shyy</dc:creator>
<dc:creator>Erdan Dong</dc:creator>
<dc:creator>Han Xiao</dc:creator>
<dc:date>2024-07-31</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>AMPK Attenuation of β-Adrenergic Receptor-Induced Cardiac Injury via Phosphorylation of β-Arrestin-1-ser330</dc:title>
<dc:identifier>pmid:39082138</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.324762</dc:identifier>
</item>
<item>
<title>Prostacyclin Synthase Deficiency Leads to Exacerbation or Occurrence of Endothelium-Dependent Contraction and Causes Cardiovascular Disorders Mainly via the Non-TxA&lt;sub>;2&lt;/sub>; Prostanoids/TP Axis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39082135/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240731121134&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Our study demonstrates that the non-TxA(2) prostanoids/TP axis plays an essential role in mediating the augmentation of EDC and cardiovascular disorders when PGIS is deficient, suggesting TP as a promising therapeutic target in diseases associated with PGIS insufficiency.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Jul 31. doi: 10.1161/CIRCRESAHA.124.324924. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Prostaglandin I<sub>2</sub> synthesized by endothelial COX (cyclooxygenase) evokes potent vasodilation in some blood vessels but is paradoxically responsible for endothelium-dependent constriction (EDC) in others. Prostaglandin I<sub>2</sub> production and EDC may be enhanced in diseases such as hypertension. However, how PGIS (prostaglandin I<sub>2</sub> synthase) deficiency affects EDC and how this is implicated in the consequent cardiovascular pathologies remain largely unknown.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Experiments were performed with wild-type, <i>Pgis</i> knockout (<i>Pgis</i><sup><i>-</i></sup><sup>/<i>-</i></sup>) and <i>Pgis</i>/thromboxane-prostanoid receptor gene (<i>Tp</i>) double knockout (<i>Pgis</i><sup><i>-</i>/<i>-</i></sup><i>Tp</i><sup><i>-</i>/<i>-</i></sup>) mice and <i>Pgis</i><sup><i>-</i>/<i>-</i></sup> mice transplanted with unfractionated wild-type or <i>Cox-1</i><sup><i>-</i>/<i>-</i></sup> bone marrow cells, as well as human umbilical arteries. COX-derived prostanoids were measured by high-performance liquid chromatography-mass spectrometry. Vasomotor responses of distinct types of arteries were assessed by isometric force measurement. Parameters of hypertension, vascular remodeling, and cardiac hypertrophy in mice at different ages were monitored.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: PGF<sub>2α</sub>, PGE<sub>2</sub>, and a trace amount of PGD<sub>2</sub>, but not thromboxane A<sub>2</sub> (TxA<sub>2</sub>), were produced in response to acetylcholine in <i>Pgis</i><sup><i>-</i>/<i>-</i></sup> or PGIS-inhibited arteries. PGIS deficiency resulted in exacerbation or occurrence of EDC ex vivo and in vivo. Endothelium-dependent hyperpolarization was unchanged, but phosphorylation levels of eNOS (endothelial nitric oxide synthase) at Ser1177 and Thr495 were altered and NO production and the NO-dependent relaxation evoked by acetylcholine were remarkably reduced in <i>Pgis</i><sup><i>-</i>/<i>-</i></sup> aortas. <i>Pgis</i><sup><i>-</i>/<i>-</i></sup> mice developed high blood pressure and vascular remodeling at 16 to 17 weeks and subsequently cardiac hypertrophy at 24 to 26 weeks. Meanwhile, blood pressure and cardiac parameters remained normal at 8 to 10 weeks. Additional ablation of TP (TxA2 receptor) not only restrained EDC and the downregulation of NO signaling in <i>Pgis</i><sup><i>-</i>/<i>-</i></sup> mice but also ameliorated the cardiovascular abnormalities. Stimulation of <i>Pgis</i><sup><i>-</i>/<i>-</i></sup> vessels with acetylcholine in the presence of platelets led to increased TxA<sub>2</sub> generation. COX-1 disruption in bone marrow-derived cells failed to affect the development of high blood pressure and vascular remodeling in <i>Pgis</i><sup><i>-</i>/<i>-</i></sup> mice though it largely suppressed the increase of plasma TxB<sub>2</sub> (TxA<sub>2</sub> metabolite) level.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Our study demonstrates that the non-TxA<sub>2</sub> prostanoids/TP axis plays an essential role in mediating the augmentation of EDC and cardiovascular disorders when PGIS is deficient, suggesting TP as a promising therapeutic target in diseases associated with PGIS insufficiency.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39082135/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240731121134&v=2.18.0.post9+e462414">39082135</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.324924>10.1161/CIRCRESAHA.124.324924</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39082135</guid>
<pubDate>Wed, 31 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Jiahui Ge</dc:creator>
<dc:creator>Yingbi Zhou</dc:creator>
<dc:creator>Hui Li</dc:creator>
<dc:creator>Ruhui Zeng</dc:creator>
<dc:creator>Kaiqi Xie</dc:creator>
<dc:creator>Jing Leng</dc:creator>
<dc:creator>Xijian Chen</dc:creator>
<dc:creator>Gang Yu</dc:creator>
<dc:creator>Xinya Shi</dc:creator>
<dc:creator>Yineng Xu</dc:creator>
<dc:creator>Dong He</dc:creator>
<dc:creator>Pi Guo</dc:creator>
<dc:creator>Yongyin Zhou</dc:creator>
<dc:creator>Hongjun Luo</dc:creator>
<dc:creator>Wenhong Luo</dc:creator>
<dc:creator>Bin Liu</dc:creator>
<dc:date>2024-07-31</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Prostacyclin Synthase Deficiency Leads to Exacerbation or Occurrence of Endothelium-Dependent Contraction and Causes Cardiovascular Disorders Mainly via the Non-TxA&lt;sub>;2&lt;/sub>; Prostanoids/TP Axis</dc:title>
<dc:identifier>pmid:39082135</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.324924</dc:identifier>
</item>
<item>
<title>NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39078224/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240731121134&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: The study demonstrates the presence of anti-NaV1.5 autoantibodies in the majority of BrS patients, suggesting an immunopathogenic component of the syndrome beyond genetic predispositions. These autoantibodies, which could serve as additional diagnostic markers, also prompt reconsideration of the underlying mechanisms of BrS, as evidenced by their role in inducing the ECG signature of the syndrome in wild-type mice. These findings encourage a more comprehensive diagnostic approach...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jul 30:ehae480. doi: 10.1093/eurheartj/ehae480. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Patients suffering from Brugada syndrome (BrS) are predisposed to life-threatening cardiac arrhythmias. Diagnosis is challenging due to the elusive electrocardiographic (ECG) signature that often requires unconventional ECG lead placement and drug challenges to be detected. Although NaV1.5 sodium channel dysfunction is a recognized pathophysiological mechanism in BrS, only 25% of patients have detectable SCN5A variants. Given the emerging role of autoimmunity in cardiac ion channel function, this study explores the presence and potential impact of anti-NaV1.5 autoantibodies in BrS patients.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Using engineered HEK293A cells expressing recombinant NaV1.5 protein, plasma from 50 BrS patients and 50 controls was screened for anti-NaV1.5 autoantibodies via western blot, with specificity confirmed by immunoprecipitation and immunofluorescence. The impact of these autoantibodies on sodium current density and their pathophysiological effects were assessed in cellular models and through plasma injection in wild-type mice.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Anti-NaV1.5 autoantibodies were detected in 90% of BrS patients vs. 6% of controls, yielding a diagnostic area under the curve of .92, with 94% specificity and 90% sensitivity. These findings were consistent across varying patient demographics and independent of SCN5A mutation status. Electrophysiological studies demonstrated a significant reduction specifically in sodium current density. Notably, mice injected with BrS plasma showed Brugada-like ECG abnormalities, supporting the pathogenic role of these autoantibodies.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: The study demonstrates the presence of anti-NaV1.5 autoantibodies in the majority of BrS patients, suggesting an immunopathogenic component of the syndrome beyond genetic predispositions. These autoantibodies, which could serve as additional diagnostic markers, also prompt reconsideration of the underlying mechanisms of BrS, as evidenced by their role in inducing the ECG signature of the syndrome in wild-type mice. These findings encourage a more comprehensive diagnostic approach and point to new avenues for therapeutic research.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39078224/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240731121134&v=2.18.0.post9+e462414">39078224</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae480>10.1093/eurheartj/ehae480</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39078224</guid>
<pubDate>Tue, 30 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Adriana Tarantino</dc:creator>
<dc:creator>Giuseppe Ciconte</dc:creator>
<dc:creator>Dario Melgari</dc:creator>
<dc:creator>Anthony Frosio</dc:creator>
<dc:creator>Andrea Ghiroldi</dc:creator>
<dc:creator>Marco Piccoli</dc:creator>
<dc:creator>Marco Villa</dc:creator>
<dc:creator>Pasquale Creo</dc:creator>
<dc:creator>Serena Calamaio</dc:creator>
<dc:creator>Valerio Castoldi</dc:creator>
<dc:creator>Simona Coviello</dc:creator>
<dc:creator>Emanuele Micaglio</dc:creator>
<dc:creator>Federica Cirillo</dc:creator>
<dc:creator>Emanuela Teresina Locati</dc:creator>
<dc:creator>Gabriele Negro</dc:creator>
<dc:creator>Antonio Boccellino</dc:creator>
<dc:creator>Flavio Mastrocinque</dc:creator>
<dc:creator>Žarko Ćalović</dc:creator>
<dc:creator>Stefano Ricagno</dc:creator>
<dc:creator>Letizia Leocani</dc:creator>
<dc:creator>Gabriele Vicedomini</dc:creator>
<dc:creator>Vincenzo Santinelli</dc:creator>
<dc:creator>Ilaria Rivolta</dc:creator>
<dc:creator>Luigi Anastasia</dc:creator>
<dc:creator>Carlo Pappone</dc:creator>
<dc:date>2024-07-30</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications</dc:title>
<dc:identifier>pmid:39078224</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae480</dc:identifier>
</item>
<item>
<title>Prophylactic perigraft to right atrial shunt controls bleeding from the right coronary ostial anastomotic leak</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39078206/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240731121134&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jul 30:ehae487. doi: 10.1093/eurheartj/ehae487. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39078206/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240731121134&v=2.18.0.post9+e462414">39078206</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae487>10.1093/eurheartj/ehae487</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39078206</guid>
<pubDate>Tue, 30 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Zihao Li</dc:creator>
<dc:creator>Hongwei Zhang</dc:creator>
<dc:creator>Zhao Li</dc:creator>
<dc:date>2024-07-30</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Prophylactic perigraft to right atrial shunt controls bleeding from the right coronary ostial anastomotic leak</dc:title>
<dc:identifier>pmid:39078206</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae487</dc:identifier>
</item>
<item>
<title>Potential new therapeutic target for HFpEF</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39075216/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240731121134&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Jul 29. doi: 10.1038/s41569-024-01066-2. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39075216/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240731121134&v=2.18.0.post9+e462414">39075216</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01066-2>10.1038/s41569-024-01066-2</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39075216</guid>
<pubDate>Mon, 29 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Irene Fernández-Ruiz</dc:creator>
<dc:date>2024-07-29</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Potential new therapeutic target for HFpEF</dc:title>
<dc:identifier>pmid:39075216</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01066-2</dc:identifier>
</item>
<item>
<title>Correction to: 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39074185/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240731121134&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 30;150(5):e105. doi: 10.1161/CIR.0000000000001272. Epub 2024 Jul 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39074185/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240731121134&v=2.18.0.post9+e462414">39074185</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001272>10.1161/CIR.0000000000001272</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39074185</guid>
<pubDate>Mon, 29 Jul 2024 06:00:00 -0400</pubDate>
<dc:date>2024-07-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines</dc:title>
<dc:identifier>pmid:39074185</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001272</dc:identifier>
</item>
<item>
<title>IGFBP7: From Senescence Biomarker to a Vaccine for Heart Failure</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39074184/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240731121134&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 30;150(5):390-392. doi: 10.1161/CIRCULATIONAHA.124.067059. Epub 2024 Jul 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39074184/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240731121134&v=2.18.0.post9+e462414">39074184</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.067059>10.1161/CIRCULATIONAHA.124.067059</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39074184</guid>
<pubDate>Mon, 29 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Joseph Pierre Aboumsallem</dc:creator>
<dc:creator>Rudolf A de Boer</dc:creator>
<dc:date>2024-07-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>IGFBP7: From Senescence Biomarker to a Vaccine for Heart Failure</dc:title>
<dc:identifier>pmid:39074184</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.067059</dc:identifier>
</item>
<item>
<title>Response by Lambiase and van Duijvenboden to Letter Regarding Article, "Prognostic Significance of Different Ventricular Ectopic Burdens During Submaximal Exercise in Asymptomatic UK Biobank Subjects"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39074183/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240731121134&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 30;150(5):e104. doi: 10.1161/CIRCULATIONAHA.124.069705. Epub 2024 Jul 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39074183/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240731121134&v=2.18.0.post9+e462414">39074183</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069705>10.1161/CIRCULATIONAHA.124.069705</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39074183</guid>
<pubDate>Mon, 29 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Pier D Lambiase</dc:creator>
<dc:creator>Stefan van Duijvenboden</dc:creator>
<dc:date>2024-07-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Response by Lambiase and van Duijvenboden to Letter Regarding Article, "Prognostic Significance of Different Ventricular Ectopic Burdens During Submaximal Exercise in Asymptomatic UK Biobank Subjects"</dc:title>
<dc:identifier>pmid:39074183</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069705</dc:identifier>
</item>
<item>
<title>ECG Challenge: The Eye Sees Only What the Mind Is Prepared to Comprehend</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39074182/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240731121134&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 30;150(5):411-413. doi: 10.1161/CIRCULATIONAHA.124.070453. Epub 2024 Jul 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39074182/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240731121134&v=2.18.0.post9+e462414">39074182</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070453>10.1161/CIRCULATIONAHA.124.070453</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39074182</guid>
<pubDate>Mon, 29 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Suresh Kumar Sukumaran</dc:creator>
<dc:creator>Anandaraja Subramanian</dc:creator>
<dc:creator>Raja J Selvaraj</dc:creator>
<dc:date>2024-07-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>ECG Challenge: The Eye Sees Only What the Mind Is Prepared to Comprehend</dc:title>
<dc:identifier>pmid:39074182</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070453</dc:identifier>
</item>
<item>
<title>Letter by Katsouras Regarding Article, "Prognostic Significance of Different Ventricular Ectopic Burdens During Submaximal Exercise in Asymptomatic UK Biobank Subjects"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39074181/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240731121134&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 30;150(5):e102-e103. doi: 10.1161/CIRCULATIONAHA.124.068557. Epub 2024 Jul 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39074181/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240731121134&v=2.18.0.post9+e462414">39074181</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.068557>10.1161/CIRCULATIONAHA.124.068557</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39074181</guid>
<pubDate>Mon, 29 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Christos S Katsouras</dc:creator>
<dc:date>2024-07-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Letter by Katsouras Regarding Article, "Prognostic Significance of Different Ventricular Ectopic Burdens During Submaximal Exercise in Asymptomatic UK Biobank Subjects"</dc:title>
<dc:identifier>pmid:39074181</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.068557</dc:identifier>
</item>
<item>
<title>General Capillary Endothelial Cells Undergo Reprogramming Into Arterial Endothelial Cells in Pulmonary Hypertension Through HIF-2α/Notch4 Pathway</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39074180/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240731121134&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 30;150(5):414-417. doi: 10.1161/CIRCULATIONAHA.123.067981. Epub 2024 Jul 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39074180/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240731121134&v=2.18.0.post9+e462414">39074180</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067981>10.1161/CIRCULATIONAHA.123.067981</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39074180</guid>
<pubDate>Mon, 29 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Bin Liu</dc:creator>
<dc:creator>Dan Yi</dc:creator>
<dc:creator>Xiaomei Xia</dc:creator>
<dc:creator>Karina Ramirez</dc:creator>
<dc:creator>Hanqiu Zhao</dc:creator>
<dc:creator>Yanhong Cao</dc:creator>
<dc:creator>Ankit Tripathi</dc:creator>
<dc:creator>Ryan Dong</dc:creator>
<dc:creator>Anton Gao</dc:creator>
<dc:creator>Hongxu Ding</dc:creator>
<dc:creator>Shenfeng Qiu</dc:creator>
<dc:creator>Vladimir V Kalinichenko</dc:creator>
<dc:creator>You-Yang Zhao</dc:creator>
<dc:creator>Michael B Fallon</dc:creator>
<dc:creator>Zhiyu Dai</dc:creator>
<dc:date>2024-07-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>General Capillary Endothelial Cells Undergo Reprogramming Into Arterial Endothelial Cells in Pulmonary Hypertension Through HIF-2α/Notch4 Pathway</dc:title>
<dc:identifier>pmid:39074180</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067981</dc:identifier>
</item>
<item>
<title>Myocardial Regeneration: Feasible or Fantasy?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39074179/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240731121134&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jul 30;150(5):347-349. doi: 10.1161/CIRCULATIONAHA.124.070136. Epub 2024 Jul 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39074179/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240731121134&v=2.18.0.post9+e462414">39074179</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070136>10.1161/CIRCULATIONAHA.124.070136</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39074179</guid>
<pubDate>Mon, 29 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Eric N Olson</dc:creator>
<dc:date>2024-07-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Myocardial Regeneration: Feasible or Fantasy?</dc:title>
<dc:identifier>pmid:39074179</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070136</dc:identifier>
</item>
<item>
<title>Endothelial Dysfunction in Youth-Onset Type 2 Diabetes: A Clinical Translational Study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39069898/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240731121134&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Coronary and brachial endothelial dysfunction was evident in Y-T2D who were within 5 years of diagnosis and did not have severe hyperglycemia or dyslipidemia. Plasma-derived small extracellular vesicles induced markers of endothelial dysfunction, which corroborated accelerated subclinical coronary atherosclerosis as an early feature in Y-T2D.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Jul 29. doi: 10.1161/CIRCRESAHA.124.324272. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Youth-onset type 2 diabetes (Y-T2D) is associated with increased risk for coronary atherosclerotic disease, but the timing of the earliest pathological features and evidence of cardiac endothelial dysfunction have not been evaluated in this population. Magnetic resonance imaging functional imaging may detect early and direct endothelial dysfunction in the absence of classical risk factors (severe hyperglycemia, hypertension, and hyperlipidemia). Using cardiac magnetic resonance imaging functional imaging, we evaluated peripheral and coronary endothelial artery structure and function in young adults with Y-T2D diagnosed ≤5 years compared with age-matched healthy peers. We isolated and characterized plasma-derived small extracellular vesicles and evaluated their effects on inflammatory and signaling biomarkers in healthy human coronary artery endothelial cells to validate the imaging findings.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Right coronary wall thickness, coronary artery flow-mediated dilation, and brachial artery flow-mediated dilation were measured at baseline and during isometric handgrip exercise using a 3.0T magnetic resonance imaging. Human coronary artery endothelial cells were treated with Y-T2D plasma-derived small extracellular vesicles. Protein expression was measured by Western blot analysis, oxidative stress was measured using the redox-sensitive probe dihydroethidium, and nitric oxide levels were measured by 4-amino-5-methylamino-2',7'-difluororescein diacetate.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Y-T2D (n=20) had higher hemoglobin A1c and high-sensitivity C-reactive protein, but similar total and LDL (low-density lipoprotein)-cholesterol compared with healthy peers (n=16). Y-T2D had greater coronary wall thickness (1.33±0.13 versus 1.22±0.13 mm; <i>P</i>=0.04) and impaired endothelial function: coronary artery flow-mediated dilation (-3.1±15.5 versus 15.9±17.3%; <i>P</i>&lt;0.01) and brachial artery flow-mediated dilation (6.7±14.7 versus 26.4±15.2%; <i>P</i>=0.001). Y-T2D plasma-derived small extracellular vesicles reduced phosphorylated endothelial nitric oxide synthase expression and nitric oxide levels, increased reactive oxygen species production, and elevated ICAM (intercellular adhesion molecule)-mediated inflammatory pathways in human coronary artery endothelial cells.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Coronary and brachial endothelial dysfunction was evident in Y-T2D who were within 5 years of diagnosis and did not have severe hyperglycemia or dyslipidemia. Plasma-derived small extracellular vesicles induced markers of endothelial dysfunction, which corroborated accelerated subclinical coronary atherosclerosis as an early feature in Y-T2D.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02830308.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39069898/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240731121134&v=2.18.0.post9+e462414">39069898</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.324272>10.1161/CIRCRESAHA.124.324272</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39069898</guid>
<pubDate>Mon, 29 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Khalid Zabd-Elmoniem</dc:creator>
<dc:creator>Jehad Edwan</dc:creator>
<dc:creator>Katrina B Dietsche</dc:creator>
<dc:creator>Alfredo Villalobos-Perez</dc:creator>
<dc:creator>Nour Shams</dc:creator>
<dc:creator>Jatin Matta</dc:creator>
<dc:creator>Leilah Baumgarten</dc:creator>
<dc:creator>Waleed N Qaddumi</dc:creator>
<dc:creator>Sydney A Dixon</dc:creator>
<dc:creator>Aruba Chowdhury</dc:creator>
<dc:creator>Michael Stagliano</dc:creator>
<dc:creator>Lilian Mabundo</dc:creator>
<dc:creator>Annemarie Wentzel</dc:creator>
<dc:creator>Colleen Hadigan</dc:creator>
<dc:creator>Ahmed M Gharib</dc:creator>
<dc:creator>Stephanie T Chung</dc:creator>
<dc:date>2024-07-29</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Endothelial Dysfunction in Youth-Onset Type 2 Diabetes: A Clinical Translational Study</dc:title>
<dc:identifier>pmid:39069898</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.324272</dc:identifier>
</item>
<item>
<title>Extensive structural rearrangement of intraflagellar transport trains underpins bidirectional cargo transport</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39067443/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240731121134&amp;v=2.18.0.post9+e462414
      <description>Bidirectional transport in cilia is carried out by polymers of the IFTA and IFTB protein complexes, called anterograde and retrograde intraflagellar transport (IFT) trains. Anterograde trains deliver cargoes from the cell to the cilium tip, then convert into retrograde trains for cargo export. We set out to understand how the IFT complexes can perform these two directly opposing roles before and after conversion. We use cryoelectron tomography and in situ cross-linking mass spectrometry to...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 23:S0092-8674(24)00715-3. doi: 10.1016/j.cell.2024.06.041. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Bidirectional transport in cilia is carried out by polymers of the IFTA and IFTB protein complexes, called anterograde and retrograde intraflagellar transport (IFT) trains. Anterograde trains deliver cargoes from the cell to the cilium tip, then convert into retrograde trains for cargo export. We set out to understand how the IFT complexes can perform these two directly opposing roles before and after conversion. We use cryoelectron tomography and in situ cross-linking mass spectrometry to determine the structure of retrograde IFT trains and compare it with the known structure of anterograde trains. The retrograde train is a 2-fold symmetric polymer organized around a central thread of IFTA complexes. We conclude that anterograde-to-retrograde remodeling involves global rearrangements of the IFTA/B complexes and requires complete disassembly of the anterograde train. Finally, we describe how conformational changes to cargo-binding sites facilitate unidirectional cargo transport in a bidirectional system.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39067443/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240731121134&v=2.18.0.post9+e462414">39067443</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.041>10.1016/j.cell.2024.06.041</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39067443</guid>
<pubDate>Sat, 27 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Samuel E Lacey</dc:creator>
<dc:creator>Andrea Graziadei</dc:creator>
<dc:creator>Gaia Pigino</dc:creator>
<dc:date>2024-07-27</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Extensive structural rearrangement of intraflagellar transport trains underpins bidirectional cargo transport</dc:title>
<dc:identifier>pmid:39067443</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.041</dc:identifier>
</item>
<item>
<title>Translational potential of mouse models of human metabolic disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39067442/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240731121134&amp;v=2.18.0.post9+e462414
      <description>Obesity causes significant morbidity and mortality globally. Research in the last three decades has delivered a step-change in our understanding of the fundamental mechanisms that regulate energy homeostasis, building on foundational discoveries in mouse models of metabolic disease. However, not all findings made in rodents have translated to humans, hampering drug discovery in this field. Here, we review how studies in mice and humans have informed our current framework for understanding energy...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 24:S0092-8674(24)00771-2. doi: 10.1016/j.cell.2024.07.011. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Obesity causes significant morbidity and mortality globally. Research in the last three decades has delivered a step-change in our understanding of the fundamental mechanisms that regulate energy homeostasis, building on foundational discoveries in mouse models of metabolic disease. However, not all findings made in rodents have translated to humans, hampering drug discovery in this field. Here, we review how studies in mice and humans have informed our current framework for understanding energy homeostasis, discuss their challenges and limitations, and offer a perspective on how human studies may play an increasingly important role in the discovery of disease mechanisms and identification of therapeutic targets in the future.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39067442/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240731121134&v=2.18.0.post9+e462414">39067442</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.07.011>10.1016/j.cell.2024.07.011</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39067442</guid>
<pubDate>Sat, 27 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>I Sadaf Farooqi</dc:creator>
<dc:creator>Yong Xu</dc:creator>
<dc:date>2024-07-27</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Translational potential of mouse models of human metabolic disease</dc:title>
<dc:identifier>pmid:39067442</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.07.011</dc:identifier>
</item>
<item>
<title>Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39059381/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240731121134&amp;v=2.18.0.post9+e462414
      <description>Plasmodium falciparum reticulocyte-binding protein homolog 5 (RH5) is the most advanced blood-stage malaria vaccine candidate and is being evaluated for efficacy in endemic regions, emphasizing the need to study the underlying antibody response to RH5 during natural infection, which could augment or counteract responses to vaccination. Here, we found that RH5-reactive B cells were rare, and circulating immunoglobulin G (IgG) responses to RH5 were short-lived in malaria-exposed Malian...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 17:S0092-8674(24)00711-6. doi: 10.1016/j.cell.2024.06.037. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Plasmodium falciparum reticulocyte-binding protein homolog 5 (RH5) is the most advanced blood-stage malaria vaccine candidate and is being evaluated for efficacy in endemic regions, emphasizing the need to study the underlying antibody response to RH5 during natural infection, which could augment or counteract responses to vaccination. Here, we found that RH5-reactive B cells were rare, and circulating immunoglobulin G (IgG) responses to RH5 were short-lived in malaria-exposed Malian individuals, despite repeated infections over multiple years. RH5-specific monoclonal antibodies isolated from eight malaria-exposed individuals mostly targeted non-neutralizing epitopes, in contrast to antibodies isolated from five RH5-vaccinated, malaria-naive UK individuals. However, MAD8-151 and MAD8-502, isolated from two malaria-exposed Malian individuals, were among the most potent neutralizers out of 186 antibodies from both cohorts and targeted the same epitopes as the most potent vaccine-induced antibodies. These results suggest that natural malaria infection may boost RH5-vaccine-induced responses and provide a clear strategy for the development of next-generation RH5 vaccines.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39059381/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240731121134&v=2.18.0.post9+e462414">39059381</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.037>10.1016/j.cell.2024.06.037</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39059381</guid>
<pubDate>Fri, 26 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Lawrence T Wang</dc:creator>
<dc:creator>Andrew J R Cooper</dc:creator>
<dc:creator>Brendan Farrell</dc:creator>
<dc:creator>Kazutoyo Miura</dc:creator>
<dc:creator>Ababacar Diouf</dc:creator>
<dc:creator>Nicole Müller-Sienerth</dc:creator>
<dc:creator>Cécile Crosnier</dc:creator>
<dc:creator>Lauren Purser</dc:creator>
<dc:creator>Payton J Kirtley</dc:creator>
<dc:creator>Maciej Maciuszek</dc:creator>
<dc:creator>Jordan R Barrett</dc:creator>
<dc:creator>Kirsty McHugh</dc:creator>
<dc:creator>Rodney Ogwang</dc:creator>
<dc:creator>Courtney Tucker</dc:creator>
<dc:creator>Shanping Li</dc:creator>
<dc:creator>Safiatou Doumbo</dc:creator>
<dc:creator>Didier Doumtabe</dc:creator>
<dc:creator>Chul-Woo Pyo</dc:creator>
<dc:creator>Jeff Skinner</dc:creator>
<dc:creator>Carolyn M Nielsen</dc:creator>
<dc:creator>Sarah E Silk</dc:creator>
<dc:creator>Kassoum Kayentao</dc:creator>
<dc:creator>Aissata Ongoiba</dc:creator>
<dc:creator>Ming Zhao</dc:creator>
<dc:creator>Doan C Nguyen</dc:creator>
<dc:creator>F Eun-Hyung Lee</dc:creator>
<dc:creator>Angela M Minassian</dc:creator>
<dc:creator>Daniel E Geraghty</dc:creator>
<dc:creator>Boubacar Traore</dc:creator>
<dc:creator>Robert A Seder</dc:creator>
<dc:creator>Brandon K Wilder</dc:creator>
<dc:creator>Peter D Crompton</dc:creator>
<dc:creator>Gavin J Wright</dc:creator>
<dc:creator>Carole A Long</dc:creator>
<dc:creator>Simon J Draper</dc:creator>
<dc:creator>Matthew K Higgins</dc:creator>
<dc:creator>Joshua Tan</dc:creator>
<dc:date>2024-07-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5</dc:title>
<dc:identifier>pmid:39059381</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.037</dc:identifier>
</item>
<item>
<title>Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39059380/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240731121134&amp;v=2.18.0.post9+e462414
      <description>The highly conserved and essential Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRH5) has emerged as the leading target for vaccines against the disease-causing blood stage of malaria. However, the features of the human vaccine-induced antibody response that confer highly potent inhibition of malaria parasite invasion into red blood cells are not well defined. Here, we characterize 236 human IgG monoclonal antibodies, derived from 15 donors, induced by the most advanced PfRH5...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 18:S0092-8674(24)00655-X. doi: 10.1016/j.cell.2024.06.015. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The highly conserved and essential Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRH5) has emerged as the leading target for vaccines against the disease-causing blood stage of malaria. However, the features of the human vaccine-induced antibody response that confer highly potent inhibition of malaria parasite invasion into red blood cells are not well defined. Here, we characterize 236 human IgG monoclonal antibodies, derived from 15 donors, induced by the most advanced PfRH5 vaccine. We define the antigenic landscape of this molecule and establish that epitope specificity, antibody association rate, and intra-PfRH5 antibody interactions are key determinants of functional anti-parasitic potency. In addition, we identify a germline IgG gene combination that results in an exceptionally potent class of antibody and demonstrate its prophylactic potential to protect against P. falciparum parasite challenge in vivo. This comprehensive dataset provides a framework to guide rational design of next-generation vaccines and prophylactic antibodies to protect against blood-stage malaria.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39059380/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240731121134&v=2.18.0.post9+e462414">39059380</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.015>10.1016/j.cell.2024.06.015</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39059380</guid>
<pubDate>Fri, 26 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Jordan R Barrett</dc:creator>
<dc:creator>Dimitra Pipini</dc:creator>
<dc:creator>Nathan D Wright</dc:creator>
<dc:creator>Andrew J R Cooper</dc:creator>
<dc:creator>Giacomo Gorini</dc:creator>
<dc:creator>Doris Quinkert</dc:creator>
<dc:creator>Amelia M Lias</dc:creator>
<dc:creator>Hannah Davies</dc:creator>
<dc:creator>Cassandra A Rigby</dc:creator>
<dc:creator>Maya Aleshnick</dc:creator>
<dc:creator>Barnabas G Williams</dc:creator>
<dc:creator>William J Bradshaw</dc:creator>
<dc:creator>Neil G Paterson</dc:creator>
<dc:creator>Thomas Martinson</dc:creator>
<dc:creator>Payton Kirtley</dc:creator>
<dc:creator>Luc Picard</dc:creator>
<dc:creator>Christine D Wiggins</dc:creator>
<dc:creator>Francesca R Donnellan</dc:creator>
<dc:creator>Lloyd D W King</dc:creator>
<dc:creator>Lawrence T Wang</dc:creator>
<dc:creator>Jonathan F Popplewell</dc:creator>
<dc:creator>Sarah E Silk</dc:creator>
<dc:creator>Jed de Ruiter Swain</dc:creator>
<dc:creator>Katherine Skinner</dc:creator>
<dc:creator>Vinayaka Kotraiah</dc:creator>
<dc:creator>Amy R Noe</dc:creator>
<dc:creator>Randall S MacGill</dc:creator>
<dc:creator>C Richter King</dc:creator>
<dc:creator>Ashley J Birkett</dc:creator>
<dc:creator>Lorraine A Soisson</dc:creator>
<dc:creator>Angela M Minassian</dc:creator>
<dc:creator>Douglas A Lauffenburger</dc:creator>
<dc:creator>Kazutoyo Miura</dc:creator>
<dc:creator>Carole A Long</dc:creator>
<dc:creator>Brandon K Wilder</dc:creator>
<dc:creator>Lizbé Koekemoer</dc:creator>
<dc:creator>Joshua Tan</dc:creator>
<dc:creator>Carolyn M Nielsen</dc:creator>
<dc:creator>Kirsty McHugh</dc:creator>
<dc:creator>Simon J Draper</dc:creator>
<dc:date>2024-07-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype</dc:title>
<dc:identifier>pmid:39059380</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.015</dc:identifier>
</item>
<item>
<title>"Boosting" tumor immunity in elderly mice by hyperactivating dendritic cells</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39059365/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240731121134&amp;v=2.18.0.post9+e462414
      <description>Immunosenescence poses a significant challenge to tumor immunotherapy in elderly individuals. In this issue of Cell, Zhivaki et al. elucidate that dendritic cells "hyperactivated" by specific adjuvants elicit T(H)1-skewed CD4^(+) T cell responses in a manner contingent on the NLRP3 inflammasome, which can eliminate tumors in aged mice.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 25;187(15):3885-3887. doi: 10.1016/j.cell.2024.06.025.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Immunosenescence poses a significant challenge to tumor immunotherapy in elderly individuals. In this issue of Cell, Zhivaki et al. elucidate that dendritic cells "hyperactivated" by specific adjuvants elicit T<sub>H</sub>1-skewed CD4<sup>+</sup> T cell responses in a manner contingent on the NLRP3 inflammasome, which can eliminate tumors in aged mice.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39059365/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240731121134&v=2.18.0.post9+e462414">39059365</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.025>10.1016/j.cell.2024.06.025</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39059365</guid>
<pubDate>Fri, 26 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Jiaqi Liu</dc:creator>
<dc:creator>Feng Shao</dc:creator>
<dc:date>2024-07-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>"Boosting" tumor immunity in elderly mice by hyperactivating dendritic cells</dc:title>
<dc:identifier>pmid:39059365</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.025</dc:identifier>
</item>
<item>
<title>Translating metabolic and cardiovascular research into effective treatments: What's next?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39059364/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240731121134&amp;v=2.18.0.post9+e462414
      <description>The future of healthcare for cardiovascular diseases holds immense promise, not only based in new discoveries in cardiac metabolism but also in translating them to solutions for critical challenges faced by society. Here, ten scientists share their insights, shedding light on the future that lies ahead for this field.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 25;187(15):3880-3884. doi: 10.1016/j.cell.2024.06.034.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The future of healthcare for cardiovascular diseases holds immense promise, not only based in new discoveries in cardiac metabolism but also in translating them to solutions for critical challenges faced by society. Here, ten scientists share their insights, shedding light on the future that lies ahead for this field.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39059364/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240731121134&v=2.18.0.post9+e462414">39059364</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.034>10.1016/j.cell.2024.06.034</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39059364</guid>
<pubDate>Fri, 26 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Juleen R Zierath</dc:creator>
<dc:creator>Jolanda van der Velden</dc:creator>
<dc:creator>Ali Javaheri</dc:creator>
<dc:creator>Anthony Rosenzweig</dc:creator>
<dc:creator>Deborah M Muoio</dc:creator>
<dc:creator>Erin E Mulvihill</dc:creator>
<dc:creator>Tami A Martino</dc:creator>
<dc:creator>Adil Rasheed</dc:creator>
<dc:creator>Xiao-Wei Chen</dc:creator>
<dc:creator>Zoltan P Arany</dc:creator>
<dc:date>2024-07-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Translating metabolic and cardiovascular research into effective treatments: What's next?</dc:title>
<dc:identifier>pmid:39059364</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.034</dc:identifier>
</item>
<item>
<title>Metabolism in the spotlight: Dr. Giles Yeo on the impact and challenges of science communication</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39059363/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240731121134&amp;v=2.18.0.post9+e462414
      <description>In this interview with Cell, Dr. Giles Yeo shares his journey into metabolism research, his strategies for engaging audiences, and the challenges of simplifying complex concepts. He also discusses the impact of social media, the advantages of podcasting, and the question he's most afraid of.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 25;187(15):3877-3879. doi: 10.1016/j.cell.2024.05.049.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">In this interview with Cell, Dr. Giles Yeo shares his journey into metabolism research, his strategies for engaging audiences, and the challenges of simplifying complex concepts. He also discusses the impact of social media, the advantages of podcasting, and the question he's most afraid of.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39059363/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240731121134&v=2.18.0.post9+e462414">39059363</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.05.049>10.1016/j.cell.2024.05.049</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39059363</guid>
<pubDate>Fri, 26 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Giles S H Yeo</dc:creator>
<dc:date>2024-07-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Metabolism in the spotlight: Dr. Giles Yeo on the impact and challenges of science communication</dc:title>
<dc:identifier>pmid:39059363</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.05.049</dc:identifier>
</item>
<item>
<title>Digesting the complex metabolic effects of diet on the host and microbiome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39059362/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240731121134&amp;v=2.18.0.post9+e462414
      <description>The past 50 years of interdisciplinary research in humans and model organisms has delivered unprecedented insights into the mechanisms through which diet affects energy balance. However, translating these results to prevent and treat obesity and its associated diseases remains challenging. Given the vast scope of this literature, we focus this Review on recent conceptual advances in molecular nutrition targeting the management of energy balance, including emerging dietary and pharmaceutical...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jul 25;187(15):3857-3876. doi: 10.1016/j.cell.2024.06.032.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The past 50 years of interdisciplinary research in humans and model organisms has delivered unprecedented insights into the mechanisms through which diet affects energy balance. However, translating these results to prevent and treat obesity and its associated diseases remains challenging. Given the vast scope of this literature, we focus this Review on recent conceptual advances in molecular nutrition targeting the management of energy balance, including emerging dietary and pharmaceutical interventions and their interactions with the human gut microbiome. Notably, multiple current dietary patterns of interest embrace moderate-to-high fat intake or prioritize the timing of eating over macronutrient intake. Furthermore, the rapid expansion of microbiome research findings has complicated multiple longstanding tenets of nutrition while also providing new opportunities for intervention. Continued progress promises more precise and reliable dietary recommendations that leverage our growing knowledge of the microbiome, the changing landscape of clinical interventions, and our molecular understanding of human biology.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39059362/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240731121134&v=2.18.0.post9+e462414">39059362</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.06.032>10.1016/j.cell.2024.06.032</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39059362</guid>
<pubDate>Fri, 26 Jul 2024 06:00:00 -0400</pubDate>
<dc:creator>Rachel N Carmody</dc:creator>
<dc:creator>Krista Varady</dc:creator>
<dc:creator>Peter J Turnbaugh</dc:creator>
<dc:date>2024-07-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Digesting the complex metabolic effects of diet on the host and microbiome</dc:title>
<dc:identifier>pmid:39059362</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.06.032</dc:identifier>
</item>





























</channel>
</rss>